Cargando…

Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models

BACKGROUND: Type 2 diabetes is frequently seen in patients suffering from obesity. p-synephrine and gliclazide are widely used medicines for the treatment of obesity and diabetes, respectively. OBJECTIVES: The present study was undertaken to determine the potential for interactions between p-synephr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatsavai, Leela Krishna, Kilari, Eswar Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148059/
https://www.ncbi.nlm.nih.gov/pubmed/29103851
http://dx.doi.org/10.1016/j.jaim.2017.04.010